1. Home
  2. FNGR vs PSTV Comparison

FNGR vs PSTV Comparison

Compare FNGR & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FingerMotion Inc.

FNGR

FingerMotion Inc.

HOLD

Current Price

$0.78

Market Cap

50.2M

Sector

Technology

ML Signal

HOLD

Logo PLUS THERAPEUTICS Inc.

PSTV

PLUS THERAPEUTICS Inc.

HOLD

Current Price

$6.66

Market Cap

45.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNGR
PSTV
Founded
2016
1996
Country
Singapore
United States
Employees
N/A
28
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.2M
45.4M
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
FNGR
PSTV
Price
$0.78
$6.66
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$55.00
AVG Volume (30 Days)
321.5K
126.4K
Earning Date
05-28-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.61
EPS
N/A
N/A
Revenue
$35,607,614.00
$5,213,000.00
Revenue This Year
N/A
$13.20
Revenue Next Year
N/A
$261.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.75
$0.13
52 Week High
$3.22
$8.00

Technical Indicators

Market Signals
Indicator
FNGR
PSTV
Relative Strength Index (RSI) 41.06 62.17
Support Level $0.78 $0.37
Resistance Level $1.75 $6.65
Average True Range (ATR) 0.10 0.57
MACD -0.00 -0.04
Stochastic Oscillator 10.37 70.67

Price Performance

Historical Comparison
FNGR
PSTV

About FNGR FingerMotion Inc.

FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company's business line includes Telecommunications Products and Services, Value Added Products and Services, Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Share on Social Networks: